Royal Biologics
NJ - HackensackBiotechnology
Focus: Royal Biologics is a public biotechnology company headquartered in Hackensack, NJ, specializing in autologous and live cell therapies for unmet medical needs.
Profile data last refreshed Yesterday · AI intelligence enriched 1w ago
Funding Stage
PUBLIC
Open Jobs
0
About Royal Biologics
AI assessmentNot HiringNo open roles listed right now. Follow Royal Biologics to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Amnio-Maxx® Dual Layer Amnion Patch
Post-LOE
Phase 4 stage suggests commercialized product with ongoing clinical validation in diabetic foot ulcer treatment.
Pipeline & Clinical Trials
Amnio-Maxx® Dual Layer Amnion Patch
Diabetic Foot Ulcer (DFU)Help build intelligence for Royal Biologics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.